skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Design, Synthesis and X-Ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Su

Journal Article · · ChemMedChem

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1867472
Journal Information:
ChemMedChem, Vol. 17, Issue (9)
Country of Publication:
United States
Language:
ENGLISH

References (56)

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study journal August 2010
Improved survival in HIV-infected persons: consequences and perspectives journal July 2007
The Effect of Highly Active Antiretroviral Therapy on the Survival of HIV-Infected Children in a Resource-Deprived Setting: A Cohort Study journal June 2011
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic journal January 2010
Prevention of HIV-1 Infection with Early Antiretroviral Therapy journal August 2011
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 journal December 2021
International AIDS Society global scientific strategy: towards an HIV cure 2016 journal July 2016
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS journal January 2016
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications journal May 2011
Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options journal April 2010
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV journal December 2007
Novel bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro journal September 2003
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis journal January 2012
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients journal January 2009
Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors journal March 2011
Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors (II) journal April 2015
Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands journal May 2015
Design and synthesis of potent HIV-1 protease inhibitors with ( S )-tetrahydrofuran-tertiary amine-acetamide as P2−ligand: Structure−activity studies and biological evaluation journal September 2017
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group journal May 2016
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors journal November 2017
Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV journal January 2012
Verstärkung der Bindung an das Proteinrückgrat - ein fruchtbares Konzept gegen die Arzneimittelresistenz von HIV journal January 2012
Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure–Activity Studies, Biological and X-ray Structural Analysis journal May 2018
Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants journal April 2017
Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants journal March 2018
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency journal October 2017
Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance journal January 2008
Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies journal April 2020
Protein conformational dynamics in the mechanism of HIV-1 protease catalysis journal December 2011
Nonpeptidal P 2 Ligands for HIV Protease Inhibitors:  Structure-Based Design, Synthesis, and Biological Evaluation journal January 1996
Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere journal March 1998
Indole alkaloids. Enantioselective synthesis of (–)-alloyohimbane by a chemoenzymatic approach journal January 1987
Methods for pyranoannulation: an approach to a new class of polyethers journal August 1985
Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones journal November 1983
Factors Associated with the Selection of Mutations Conferring Resistance to Protease Inhibitors (PIs) in PI-Experienced Patients Displaying Treatment Failure on Darunavir journal November 2007
Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials journal March 2008
A simple, continuous fluorometric assay for HIV protease journal December 1990
In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Protease Inhibitors journal September 2010
Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1 journal September 2012
High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains journal April 2004
Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114 journal October 2006
INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design journal June 1998
Highly Drug-Resistant HIV-1 Protease Mutant PRS17 Shows Enhanced Binding to Substrate Analogues journal May 2019
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Phaser crystallographic software journal July 2007
Overview of the CCP 4 suite and current developments journal March 2011
The CCP4 suite programs for protein crystallography journal September 1994
A graphical user interface to the CCP 4 program suite journal June 2003
Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters: HIV protease mutants altering hydrophobic clusters journal August 2010
A short history of SHELX journal December 2007
Refinement of Macromolecular Structures by the Maximum-Likelihood Method journal May 1997
PRODRG : a tool for high-throughput crystallography of protein–ligand complexes journal July 2004
JLigand : a graphical tool for the CCP 4 template-restraint library journal March 2012
Features and development of Coot journal March 2010
Coot model-building tools for molecular graphics journal November 2004
The Protein Data Bank journal January 2000